Functional genomics of the nicotinic acetylcholine receptor gene family of the nematode, Caenorhabditis elegans

BioEssays

Volumn 26, Issue 1, 2004, Pages 39-49

  Jones, Andrew K ^a   Sattelle, David B ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALPHA BUNGAROTOXIN; AMYLOID BETA PROTEIN; ANTHELMINTIC AGENT; BUTAMISOLE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; DIHYDRO BETA ERYTHROIDINE; GREEN FLUORESCENT PROTEIN; IVERMECTIN; LEVAMISOLE; MECAMYLAMINE; METHYLLYCACONITINE; MORANTEL; NEOSURUGATOXIN; NICOTINIC RECEPTOR; OXANTEL; PESTICIDE; PROTEIN KINASE C; PYRANTEL; RECEPTOR SUBUNIT; RECOMBINANT PROTEIN; STRYCHNINE; TUBOCURARINE CHLORIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL; BINDING SITE; BIOLOGICAL MODEL; CAENORHABDITIS ELEGANS; CHEMISTRY; CHOLINERGIC SYSTEM; GENE EXPRESSION; GENETICS; GENOMICS; HUMAN; METABOLISM; MOLECULAR GENETICS; MULTIGENE FAMILY; NEMATODE; NERVE CELL; NONHUMAN; PHYLOGENY; PHYSIOLOGY; PROTEIN MOTIF; REVIEW; SEQUENCE HOMOLOGY; TISSUE DISTRIBUTION;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; CAENORHABDITIS ELEGANS; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; NEURONS; PHYLOGENY; RECEPTORS, NICOTINIC; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; TISSUE DISTRIBUTION;

CAENORHABDITIS; CAENORHABDITIS ELEGANS;

EID: 0345743610     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.10377     Document Type: Review

References (93)

1. Langley JN. On the contraction of muscle chiefly in relation to the presence of receptive substances. J Physiol (Lond) 1907;36:347-384.
2. Bennett MR. The concept of transmitter receptors: 100 years on. Neuropharmacology 2000;39:523-546.
3. Changeux JP, Kasai M, Lee CY. Use of a snake venom toxin to characterize the cholinergic receptor protein. Proc Natl Acad Sci USA 1970;67:1241-1247.
4. Sumikawa K, Houghton M, Smith JC, Bell L, Richards BM, Barnard EA. The molecular cloning and characterisation of cDNA coding for the alpha subunit of the acetylcholine receptor. Nucleic Acids Res 1982;10:5809-5822.
5. Changeux JP, Edelstein SJ. Allosteric receptors after 30 years. Neuron 1998;21:959-980.
6. Macklin KD, Maus AD, Pereira EF, Albuquerque EX, Conti-Fine BM. Human vascular endothelial cells express functional nicotinic acetylcholine receptors. J Pharmacol Exp Ther 1998;287:435-439.
7. Bruggmann D, Lips KS, Pfeil U, Haberberger RV, Kummer W. Multiple nicotinic acetylcholine receptor alpha-subunits are expressed in the arterial system of the rat. Histochem Cell Biol 2002;118:441-447.
8. Wang H, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2002;421:384-388.
9. Camacho M, Alsford S, Jones A, Agnew A. Nicotinic acetylcholine receptors on the surface of the blood fluke Schistosoma. Mol Biochem Parasitol 1995;71:127-134.
10. Cordero-Erausquin M, Marubio LM, Klink R, Changeux JP. Nicotinic receptor function: new perspectives from knockout mice. Trends Pharmacol Sci 2000;21:211-217.
11. Mansvelder HD, McGehee DS. Cellular and synaptic mechanisms of nicotine addiction. J Neurobiol 2002;53:606-617.
12. Engel AG, Ohno K, Sine SM, Congenital myasthenic syndromes: Progress over the past decade. Muscle Nerve 2003;27:4-25.
13. Itier V, Bertrand D. Mutations of the neuronal nicotinic acetylcholine receptors and their association with ADNFLE. Neurophysiol Clin 2002;32:99-107.
14. Pereira EF, Hilmas C, Santos MD, Alkondon M, Maelicke A, Albuquerque EX. Unconventional ligands and modulators of nicotinic receptors. J Neurobiol 2002;53:479-500
15. Rashid MH, Ueda H. Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism. Brain Res 2002;953:53-62.
16. Matsuda K, Buckingham SD, Kleier D, Rauh JJ, Grauso M, Sattelle DB. Neonicotinoids: insecticides acting on insect nicotinic acetylcholine receptors. Trends Pharmacol Sci 2001;22:573-580.
17. Martin RJ. Modes of action of anthelmintic drugs. Vet J 1997;154:11-34.
18. Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974;77:71-94.
19. White JG, Southgate E, Thomson JN, Brenner S. The structure of the ventral nerve cord of Caenorhabditis elegans. Philos Trans R Soc Lond B Biol Sci 1976;275:327-348.
20. Sulston JE, Horvitz HR. Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev Biol 1977;56:110-156.
21. Sulston JE, Schierenberg E, White JG, Thomson JN. The embryonic cell lineage of the nematode Caenorhabditis elegans. Dev Biol 1983;100:64-119.
22. The C. elegans sequencing consortium. Genome sequence of the nematode C elegans: a platform for investigating biology. Science 1998;282:2012-2018.
23. Bargmann CI. Neurobiology of the Caenorhabditis elegans genome. Science 1998;282:2028-2033
24. Reeves DC, Lummis SC. The molecular basis of the structure and function of the 5-HT3 receptor: a model ligand-gated ion channel (review). Mol Membr Biol 2002;19:11-26.
25. Bormann J. The 'ABC' of GABA receptors. Trends Pharmacol Sci 2000;21:16-19
26. Legendre P. The glycinergic inhibitory synapse. Cell Mol Life Sci 2001;58:760-793.
27. Ranganathan R, Cannon SC, Horvitz HR. MOD-1 is a serotonin-gated chloride channel that modulates locomotory behaviour in C. elegans. Nature 2000;408:470-475
28. Vassilatis DK, Elliston KO, Paress PS, Hamelin M, Arena JP, Schaeffer JM, Van der Ploeg LH, Cully DF. Evolutionary relationship of the ligandgated ion channels and the avermectin-sensitive, glutamate-gated chloride channels. J Mol Evol 1997;44:501-508.
29. Zheng Y, Hirschberg B, Yuan J, Wang AP, Hunt DC, Ludmerer SW, Schmatz DM, Cully DF. Identification of two novel Drosophila melanogaster histamine-gated chloride channel subunits expressed in the eye. J Biol Chem 2002;277:2000-2005.
30. Miyazawa A, Fujiyoshi Y, Stowell M, Unwin N. Nicotinic acetylcholine receptor at 4.6 A resolution: transverse tunnels in the channel wall. J Mol Biol 1999;288:765-786.
31. Karlin A. Emerging structure of the nicotinic acetylcholine receptors. Nat Rev Neurosci 2002;3:102-114.
32. Corringer PJ, Le Novere N, Changeux JP. Nicotinic receptors at the amino acid level. Annu Rev Pharmacol Toxicol 2000;40:431-458.
33. Kao PN, Dwork AJ, Kaldany RR, Silver ML, Wideman J, Stein S, Karlin A. Identification of the alpha subunit half-cystine specifically labeled by an affinity reagent for the acetylcholine receptor binding site. J Biol Chem 1984;259:11662-11665.
34. Boyd RT. The molecular biology of neuronal nicotinic acetylcholine receptors. Crit Rev Toxicol 1997;27:299-318.
35. Sgard F, Charpantier E, Bertrand S, Walker N, Caput J, Graham D, Bertrand D, Besnard F. A novel human nicotinic receptor subunit, alpha10, that confers functionality to the alpha9-subunit. Mol Pharmacol 2002;61:150-159.
36. Treinin M, Chalfie M. A mutated acetylcholine receptor subunit causes neuronal degeneration in C. elegans. Neuron 1995;14:871-877.
37. Treinin M, Gillo B, Liebman L, Chalfie M. Two functionally dependent acetylcholine subunits are encoded in a single Caenorhabditis elegans operon. Proc Natl Acad Sci USA 1998;95:15492-15495.
38. Fleming JT, et al. Caenorhabditis elegans levamisole resistance genes lev-1, unc-29, and unc-38 encode functional acetylcholine receptor subunits. Journal of Neuroscience 1997;15:5843-5857.
39. Squire MD, Tornoe C, Baylis HA, Fleming JT, Barnard EA, Sattelle DB. Molecular cloning and functional co-expression of a Caenorhabditis elegans nicotinic acetylcholine receptor subunit (acr-2). Receptors Channels 1995;3:107-115.
40. Baylis HA, Matsuda K, Squire MD, Fleming JT, Harvey RJ, Darlison MG, Barnard EA, Sattelle DB. ACR-3, a Caenorhabditis elegans nicotinic acetylcholine receptor subunit Molecular cloning and functional expression. Receptors Channels 1997;5:149-158.
41. Ballivet M, Alliod C, Bertrand S, Bertrand D. Nicotinic acetylcholine receptors in the nematode Caenorhabditis elegans. J Mol Biol 1996;258:261-269.
42. Mongan NP, Baylis HA, Adcock C, Smith GR, Sansom MS, Sattelle DB. An extensive and diverse gene family of nicotinic acetylcholine receptor alpha subunits in Caenorhabditis elegans. Receptors and Channels 1998;6:213-228.
43. Mongan NP, Jones AK, Smith GR, Sansom MS, Sattelle DB. Novel alpha7-like nicotinic acetylcholine receptor subunits in the nematode Caenorhabditis elegans. Protein Sci 2002;11:1162-1171.
44. Imoto K, et al. Rings of negatively charged amino acids determine the acetylcholine receptor channel conductance. Nature 1988;335:645-648.
45. Galzi JL, Bertrand D, Devillers-Thiery A, Revah F, Bertrand S, Changeux JP. Functional significance of aromatic amino acids from three peptide loops of the alpha 7 neuronal nicotinic receptor site investigated by site-directed mutagenesis. FEBS Lett 1991;294:198-202.
46. Kehoe J, McIntosh JM. Two distinct nicotinic receptors, one pharmacologically similar to the vertebrate alpha7-containing receptor, mediate Cl currents in aplysia neurons. J Neurosci 1998;18:8198-8213.
47. Corriveau RA, Romano SJ, Conroy WG, Oliva L, Berg DK. Expression of neuronal acetylcholine receptor genes in vertebrate skeletal muscle during development. J Neurosci 1995;15:1372-1383.
48. Keiger CJ, Prevette D, Conroy WG, Oppenheim RW. Developmental expression of nicotinic receptors in the chlck and human spinal cord. J Comp Neurol 2003;455:86-99.
49. Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC. Green fluorescent protein as a marker for gene expression. Science 1994;263:802-805.
50. Couturier S, Bertrand D, Matter JM, Hernandez MC, Bertrand S, Millar N, Valera S, Barkas T, Ballivet M. A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homooligomeric channel blocked by alpha-BTX. Neuron 1990;5:847-856.
51. Raymond V, Mongan NP, Sattelle DB. Anthelmintic actions on homomerforming nicotinic acetylcholine receptor subunits: chicken alpha7 and ACR-16 from the nematode Caenorhabditis elegans. Neuroscience 2000;101:785-791
52. Krause RM, Buisson B, Bertrand S, Corringer PJ, Galzi JL, Changeux JP, Bertrand D. Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor. Mol Pharmacol 1998;53:283-294.
53. Blumenthal T, et al. A global analysis of Caenorhabditis elegansoperons. Nature 2002;417:851-854.
54. Yassin L, Gillo B, Kahan T, Halevi S, Eshel M, Treinin M. Characterization of the DEG-3/DES-2 receptor: a nicotinic acetylcholine receptor that mutates to cause neuronal degeneration. Mol Cell Neurosci 2001;17:589-599.
55. Papke RL, Bencherif M, Lippiello P. An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the alpha 7 subtype. Neurosci Lett 1996;213:201-204.
56. Le Novere N, Changeux JP. Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells. J Mol Evol 1995;40:155-172.
57. Fischer U, Reinhardt S, Albuquerque EX, Maelicke A. Expression of functional alpha7 nicotinic acetylcholine receptor during mammalian muscle development and denervation. Eur J Neurosci 1999;11:2856-2864.
58. Lewis JA, Wu CH, Levine JH, Berg H. Levamisole-resistant mutants of the nematode Caenorhabditis elegans appear to lack pharmacological acetylcholine receptors. Neuroscience 1980;5:967-989.
59. Lewis JA, Elmer JS, Skimming J, McLafferty S, Fleming J, McGee T. Cholinergic receptor mutants of the nematode Caenorhabditis elegans. J Neurosci 1987;7:3059-3071.
60. Richmond JE, Jorgensen EM One GABA and two acetylcholine receptors function at the C. elegans neuromuscular junction. Nat Neurosci 1999;2:791-797.
61. Fitzgerald J, Kennedy D, Viseshakul N, Cohen BN, Mattick J, Bateman JF, Forsayeth JR. UNCL, the mammalian homologue of UNC-50, is an inner nuclear membrane RNA-binding protein. Brain Res 2000;877:110-123.
62. Maryon EB, Coronado R, Anderson P. unc-68 encodes a ryanodine receptor involved in regulating C. elegans body-wall muscle contraction. J Cell Biol 1996;134:885-893.
63. Kagawa H, Takuwa K, Sakube Y. Mutations and expressions of the tropomyosin gene and the troponin C gene of Caenorhabditis elegans. Cell Struct Funct 1997;22:213-218.
64. Benian GM, L'Hernault SW, Morris ME. Additional sequence complexity in the muscle gene, unc-22, and its encoded protein, twitchin, of Caenorhabditis elegans. Genetics 1993;134:1097-1104.
65. Nguyen M, Alfonso A, Johnson CD, Rand JB. Caenorhabditis elegans mutants resistant to inhibitors of acetylcholinesterase. Genetics 1995;140:527-535.
66. Halevi S, McKay J, Palfreyman M, Yassin L, Eshel M, Jorgensen E, Treinin M. The C. elegans ric-3 gene is required for maturation of nicotinic acetylcholine receptors. Embo J 2002;21:1012-1020.
67. Waggoner LE, Dickinson KA, Poole DS, Tabuse Y, Miwa J, Schafer WR. Long-term nicotine adaptation in Caenorhabditis elegans involves PKC-dependent changes in nicotinic receptor abundance. J Neurosci 2000;20:8802-8811
68. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391:806-811.
69. Timmons L, Fire A. Specific interference by ingested dsRNA. Nature 1998;395:854.
70. Tabara H, Grishok A, Mello CC RNAi in C. elegans: soaking in the genome sequence. Science 1998;282:430-431.
71. Kamath RS, et al. Systematic functional analysis of the Caenorhabditfs elegans genome using RNAi. Nature 2003;421:231-237.
72. Simmer F, Tijsterman M, Parrish S, Koushika SP, Nonet ML, Fire A, Ahringer J, Plasterk RH. Loss of the putative RNA-directed RNA polymerase RRF-3 makes C. elegans hypersensitive to RNAi. Curr Biol 2002;12:1317-1319.
73. Kim SK, Lund J, Kiraly M, Duke K, Jiang M, Stuart JM, Eizinger A, Wylie BN, Davidson GS. A gene expression map for Caenorhabditis elegans. Science 2001;293:2087-2092.
74. Selkoe DJ. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann NY Acad Sci 2000;924:17-25.
75. Askanas V, Engel WK Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms. Curr Opin Neurol 2002;15:525-531.
76. Guan ZZ, Zhang X, Ravid R, Nordberg A. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J Neurochem 2000;74:237-243.
77. Teaktong T, Graham A, Court J, Perry R, et al. Alzheimer's disease is associated with a selective increase in alpha7 nicotinic acetylcholine receptor immunoreactivity in astrocytes. Glia 2003;41:207-211.
78. Wang HY, Lee DH, Davis CB, Shank RP. Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. J Neurochem 2000;75:1155-1161.
79. Dineley KT, Bell KA, Bui D, Sweatt JD. beta-Amyloid peptide activates alpha 7 nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Biol Chem 2002;277:25056-25061.
80. Grassi F, Palma E, Tonini R, Amici M, Ballivet M, Eusebi F. Amyloid beta(1-42) peptide alters the gating of human and mouse alpha-bungarotoxin-sensitive nicotinic receptors. J Physiol 2003;547:147-157.
81. Link CD. Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci USA 1995;92:9368-9372.
82. Link CD, Taft A, Kapulkin V, Duke K, Kim S, Fei Q, Wood DE, Sahagan BG. Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer's disease model. Neurobiol Aging 2003;24:397-413.
83. Brejc K, van Dijk WJ, Klaassen RV, Schuurmans M, van Der Oost J, Smit AB, Sixma TK. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 2001;411:269-276.
84. Yassin L, Samson AO, Halevi S, Eshel M, Treinin M. Mutations in the extracellular domain and in the membrane-spanning domains interfere with nicotinic acetylcholine receptor maturation. Biochemistry 2002;41:12329-12335.
85. Shimomura M, Okuda H, Matsuda K, Komai K, Akamatsu M, Sattelle DB. Effects of mutations of a glutamine residue in loop D of the alpha7 nicotinic acetylcholine receptor on agonist profiles for neonicotinoid insecticides and related ligands. Br J Pharmacol 2002;137:162-169.
86. Jones AK, Elgar G, Sattelle DB. The nicotinic acetylcholine receptor gene family of the pufferfish, Fugu rubnpes. Genomics 2003;82:441-451.
87. Lander ES, et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921.
88. Hodgkin J. What does a worm want with 20,000 genes? Genome Biol 2001;2: COMMENT 2008.1-2008.4.
89. Grauso M, Reenan RA, Culetto E, Sattelle DB. Novel putative nicotinic acetylcholine receptor subunit genes, Dalpha5, Dalpha6 and Dalpha7, in Drosophila metanogaster iidentify a new and highly conserved target of adenosine deaminase acting on RNA-mediated A-to-I pre-mRNA editing. Genetics 2002;160:1519-1533.
90. Harris TW, et al. WormBase: a cross-species database for comparative genomics. Nucleic Acids Res 2003;31:133-137.
91. Blaxter M, Daub J, Guiliano D, Parkinson J, Whitton C, Filarial Genome Project. The Brugia malayi genome project: expressed sequence tags and gene discovery. Trans R Soc Trop Med Hyg 2002;96:7-17.
92. Wolf FW, Heberlein U. Invertebrate models of drug abuse. J Neurobiol 2003;54:161-178.
93. Esmaeili B, Ross JM, Neades C, Miller DM 3rd, Ahringer J. The C. elegans even-skipped homologue, vab-7, specifies DB motoneurone identity and axon trajectory. Development 2002;129:853-862.